EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study

Nofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, Noga Hasson, Yaara Ben Ari, Basel Darawsha, Idan Levitan, Elad Goldberg, Michal Landes, Vladislav Litchevsky, Haim Ben-Zvi, Sharon Amit und 5 weitere

Infection · 2025-06 · 53 (3) · 1115-1127

DOI: 10.1007/s15010-024-02445-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Infection, online erschienen am 26.11.2024. Verfasst von Nofar Hezkelo Attias und 16 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel. Hauptthemen laut MEDLINE: Nocardia Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The prolonged treatment recommended for nocardiosis does not rely on strong evidence. Consequently, some clinicians opt shorter therapy in certain circumstances. We assessed the effectiveness of shorter therapy.

Methods

A multi-center retrospective cohort study comprising individuals diagnosed with nocardiosis between 2007 and 2022. We classified all patients who survived 90 days into three groups according to treatment duration: short (≤ 90 days), intermediate (91–180 days), and prolonged (> 180 days). We compared baseline characteristics (comorbidities, immune status) and nocardiosis manifestations across the unadjusted treatment groups, one-year all-cause mortality, disease relapse, and antibiotic-related adverse events to identify patients who may safely receive the short course.

Results

We detected 176 patients with nocardiosis, their median age was 65 years; 74 (42%) were women. Forty-three (24%) patients died within 90 days. Of the remaining 133, 37 (28%) patients received short therapy, 40 (30%) intermediate, and 56 (42%) prolonged treatment duration. Longer courses were more likely to be administered to patients with immunosuppression, disseminated nocardiosis, and N. farcinica infection. Within a year, 20 (15%) individuals died and 2 (2%) relapsed. Treatment duration was not associated with either mortality ( p = 0.945) or relapse ( p = 0.509). Nocardiosis was the cause of death in only one patient, receiving a prolonged course. Of 73 patients with solitary pulmonary nocardiosis, 20 (27%) received short duration. None relapsed and 2 (10%) died, both immunocompromised. The rate of AE was similar across the groups.

Conclusions

With clinically guided case-by-case patient selection nocardiosis can be safely treated for durations significantly shorter than traditionally recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nocardia InfectionsAnti-Bacterial AgentsHumansRetrospective StudiesFemaleMaleAgedMiddle AgedTreatment OutcomeAged, 80 and overAdultDuration of TherapyTime Factors

Stichwörter der Autor:innen

Immune suppressionNocardiaOpportunistic infectionsTreatment

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
  • Infectious Diseases Institute, Soroka Medical Center, Beer Sheba, Israel.
  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
  • Lev Hasharon Mental Health Center, Tzur Moshe, Israel.

Förderung

  • Tel Aviv University

Zitieren

APA

Attias, N. H., Schlaeffer-Yosef, T., Zahavi, I., Hasson, N., Ari, Y. B., Darawsha, B., Levitan, I., Goldberg, E., Landes, M., Litchevsky, V., Ben-Zvi, H., Amit, S., Nesher, L., Bishara, J., Paul, M., Yahav, D., & Margalit, I. (2025). Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study. Infection, 53(3), 1115-1127. https://doi.org/10.1007/s15010-024-02445-0

Vancouver

Attias NH, Schlaeffer-Yosef T, Zahavi I, Hasson N, Ari YB, Darawsha B, et al. Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study. Infection. 2025;53(3):1115-1127. doi:10.1007/s15010-024-02445-0

BibTeX
@article{Attias2025,
  author = {Attias, Nofar Hezkelo and Schlaeffer-Yosef, Tal and Zahavi, Itay and Hasson, Noga and Ari, Yaara Ben and Darawsha, Basel and Levitan, Idan and Goldberg, Elad and Landes, Michal and Litchevsky, Vladislav and Ben-Zvi, Haim and Amit, Sharon and Nesher, Lior and Bishara, Jihad and Paul, Mical and Yahav, Dafna and Margalit, Ili},
  title = {Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study},
  journal = {Infection},
  year = {2025},
  volume = {53},
  number = {3},
  pages = {1115--1127},
  doi = {10.1007/s15010-024-02445-0}
}
Kostenlos starten →